Masaoki Harada
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Hepatology 17
- Hepatocellular Carcinoma Treatment and Prognosis 12
-
- Prostate Cancer Treatment and Research 33
- Prostate Cancer Diagnosis and Treatment 28
- Co-authors
- Ryosuke NemotoKenkichi KoisoKiyoshi FujinamiKazuo TaraoYoshinobu KubotaYoshiyasu NakamuraHiroji UemuraAkio Shimizu
- Journals
- Cancer (9 papers)The Journal of Urology (7 papers)The Prostate (6 papers)Japanese Journal of Clinical Oncology (3 papers)Advances in experimental medicine and biology (3 papers)
- Partner nations
- JapanUnited StatesPakistan
In The Last Decade
Masaoki Harada
88 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Hepatology 280
- Pulmonary and Respiratory Medicine 640
- Cancer Research 200
- Obstetrics and Gynecology 98
- Oncology 289
Countries citing papers authored by Masaoki Harada
This map shows the geographic impact of Masaoki Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaoki Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaoki Harada more than expected).
Fields of papers citing papers by Masaoki Harada
This network shows the impact of papers produced by Masaoki Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaoki Harada. The network helps show where Masaoki Harada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaoki Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 0 | |
| 2 | 1999 | 4 | |
| 3 | [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)]. | 1996 | 1 |
| 4 | 1996 | 4 | |
| 5 | 1995 | 9 | |
| 6 | 1994 | 30 | |
| 7 | 1994 | 4 | |
| 8 | 1994 | 20 | |
| 9 | 1993 | 9 | |
| 10 | 1993 | 1 | |
| 11 | 1992 | 30 | |
| 12 | 1991 | 23 | |
| 13 | 1990 | 1 | |
| 14 | 1990 | 1 | |
| 15 | 1989 | 2 | |
| 16 | 1989 | 1 | |
| 17 | 1989 | 6 | |
| 18 | 1989 | 31 | |
| 19 | 1988 | 1 | |
| 20 | 1987 | 4 |
About Masaoki Harada
Masaoki Harada is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Rheumatology, Oncology and Epidemiology, having authored 89 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Bladder and Urothelial Cancer Treatments (11 papers), Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers), Urologic and reproductive health conditions (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Hepatology (280 citations), Pulmonary and Respiratory Medicine (640 citations), Cancer Research (200 citations), Obstetrics and Gynecology (98 citations) and Oncology (289 citations). Masaoki Harada has collaborated with scholars based in Japan, United States and Pakistan. Frequent co-authors include Ryosuke Nemoto, Kenkichi Koiso, Kiyoshi Fujinami, Kazuo Tarao, Yoshinobu Kubota, Yoshiyasu Nakamura, Hiroji Uemura, Akio Shimizu, Katsunori Uchida and Setsuo Tamai. Their work appears in journals such as Cancer, The Journal of Urology, The Prostate, Japanese Journal of Clinical Oncology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.